Business
Currency:CNY
2024/FY
Stock NameRevenueRatio
销售生物制药产品4.93B86.18%
Research and development services523.47M9.14%
授权许可收入260.76M4.56%
Other3.88M0.07%
来自经营租赁的总租金收入2.81M0.05%
Product
Currency:CNY
2024/FY
Stock NameRevenueRatio
销售生物制药产品4.93B86.18%
Research and development services523.47M9.14%
授权许可收入260.76M4.56%
Other3.88M0.07%
来自经营租赁的总租金收入2.81M0.05%
Region
Currency:CNY
2024/FY
Stock NameRevenueRatio
Chinese mainland5.05B88.15%
North America329.12M5.75%
Asia Pacific (excluding mainland China)236.86M4.14%
Europe101.41M1.77%
South America10.62M0.19%
Oceania325K0.01%
View all